Corcept Therapeutics (CORT) Earnings Date, Estimates & Call Transcripts → Do NOT read if you believe in “woke” politics (From Stansberry Research) (Ad) Free cort Stock Alerts $23.97 -0.55 (-2.24%) (As of 05/6/2024 ET) Add Compare Share Share EarningsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainabilityStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainability Earnings SummaryUpcoming Earnings DateAug. 7EstimatedActual EPS (May. 1) $0.25 Beat By $0.04 Consensus EPS (May. 1) $0.21 Read Call TranscriptListen to Call Get Corcept Therapeutics Earnings AlertsEnter your email address below to receive the latest news and earnings results for CORT and its competitors with MarketBeat's FREE daily newsletter. Skip Charts & View Estimated and Actual Earnings DataEarnings Per ShareRevenueCORT Earnings Estimates and Actuals by QuarterEarnings Estimates and Acutals by Quarter Chart DescriptionThe chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.CORT Estimated and Actual Revenue by Quarter Estimated Revenue and Actual Revenue by Quarter Chart DescriptionThe chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter. Ad InvestorPlaceThis is the ONLY AI story you should be worried aboutA.I. is creeping into every aspect of our daily lives… According to billion-dollar fund manager, Louis Navellier, it’s never been more important to A.I.-proof your wealth. He lays out three simple steps to take ASAP in his latest video.Click here to watch it now. Corcept Therapeutics Analyst EPS EstimatesQuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateCompany GuidanceQ1 20244($0.02)$0.31$0.15 Q2 20244$0.18$0.36$0.25 Q3 20244$0.11$0.38$0.24 Q4 20244$0.24$0.46$0.31 FY 202416$0.51$1.51$0.95 Q1 20252$0.21$0.29$0.25 Q2 20252$0.26$0.33$0.30 Q3 20252$0.26$0.36$0.31 Q4 20252$0.40$0.41$0.41 FY 20258$1.13$1.39$1.26 Q1 20261$0.39$0.39$0.39 CORT Earnings Date and InformationCorcept Therapeutics last issued its earnings results on May 1st, 2024. The biotechnology company reported $0.25 EPS for the quarter, beating analysts' consensus estimates of $0.21 by $0.04. The firm earned $146.80 million during the quarter, compared to the consensus estimate of $141.19 million. Its revenue for the quarter was up 38.9% compared to the same quarter last year. Corcept Therapeutics has generated $1.06 earnings per share over the last year ($1.06 diluted earnings per share) and currently has a price-to-earnings ratio of 22.6. Earnings for Corcept Therapeutics are expected to grow by 34.02% in the coming year, from $0.97 to $1.30 per share. Corcept Therapeutics has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, August 7th, 2024 based off prior year's report dates.Read More Corcept Therapeutics Earnings History by Quarter Custom Range 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 5 Years Time Frame * Start Date * End Date Export to Excel DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueCall Transcript 8/7/2024Estimated)------- 5/1/2024Q1 2024$0.21$0.25+$0.04$0.25$141.19 million$146.80 million 2/15/2024Q4 2023$0.25$0.28+$0.03$0.28$129.27 million$135.41 million 11/1/2023Q3 2023$0.22$0.28+$0.06$0.28$119.71 million$123.60 million 8/2/2023Q2 2023$0.15$0.25+$0.10$0.25$109.60 million$117.72 million 5/3/2023Q1 2023$0.20$0.14($0.06)$0.14$104.91 million$105.70 million 2/28/2023Q4 2022$0.23$0.14($0.09)$0.14$106.93 million$103.06 million Get the Latest News and Ratings for CORT and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Corcept Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 11/3/2022Q3 2022$0.23$0.30+$0.07$0.30$107.73 million$101.73 million8/3/2022Q2 2022$0.25$0.24($0.01)$0.24$101.51 million$103.39 million5/5/2022Q1 2022$0.23$0.20($0.03)$0.20$103.23 million$93.70 million 2/15/2022Q4 2021$0.22$0.26+$0.04$0.26$101.17 million$98.82 million 11/3/2021Q3 2021$0.19$0.24+$0.05$0.24$97.75 million$96.13 million 7/29/2021Q2 2021$0.14$0.21+$0.07$0.21$85.83 million$91.59 million Corcept Therapeutics Earnings - Frequently Asked Questions When is Corcept Therapeutics's earnings date? Corcept Therapeutics has not confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, August 7th, 2024 based off last year's report dates. Learn more on CORT's earnings history. Did Corcept Therapeutics beat their earnings estimates last quarter? In the previous quarter, Corcept Therapeutics (NASDAQ:CORT) reported $0.25 earnings per share (EPS) to beat the analysts' consensus estimate of $0.21 by $0.04. Learn more on analysts' earnings estimate vs. CORT's actual earnings. How can I listen to Corcept Therapeutics's earnings conference call? The conference call for Corcept Therapeutics's latest earnings report can be listened to online. Listen to Conference Call How can I read Corcept Therapeutics's conference call transcript? The conference call transcript for Corcept Therapeutics's latest earnings report can be read online. Read Transcript How much revenue does Corcept Therapeutics generate each year? Corcept Therapeutics (NASDAQ:CORT) has a recorded annual revenue of $482.38 million. How much profit does Corcept Therapeutics generate each year? Corcept Therapeutics (NASDAQ:CORT) has a recorded net income of $106.14 million. CORT has generated $1.06 earnings per share over the last four quarters. What is Corcept Therapeutics's price-to-earnings ratio? Corcept Therapeutics (NASDAQ:CORT) has a trailing price-to-earnings ratio of 22.61 and a forward price-to-earnings ratio of 24.71. What is Corcept Therapeutics's EPS forecast for next year? Corcept Therapeutics's earnings are expected to grow from $0.97 per share to $1.30 per share in the next year, which is a 34.02% increase. More Earnings Resources from MarketBeat Related Companies: Supernus Pharmaceuticals Earnings Results Taro Pharmaceutical Industries Earnings Results Axsome Therapeutics Earnings Results Xencor Earnings Results Pacira BioSciences Earnings Results OPKO Health Earnings Results Perrigo Earnings Results ADC Therapeutics Earnings Results Atea Pharmaceuticals Earnings Results Jazz Pharmaceuticals Earnings Results Earnings Tools: Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country: U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Australia Earnings Reports Latest Articles: Apple’s Earnings Show Investors Its Strength and Its WeaknessCarvana’s Q1 Earnings: A Profitability U-TurnPayPal’s Strong Earnings Growth and Strategic Evolution GE Aerospace is Ready for Liftoff After Strong EarningsTaiwan Semiconductor Earnings: AI Dominance and Future OutlookCSX Co.: The Railroad Powering Ahead with an Earnings Beat What's Driving Tesla Lower Ahead of its Earnings? This page (NASDAQ:CORT) was last updated on 5/7/2024 by MarketBeat.com Staff From Our PartnersBiden’s $374B Giveaway Into This SectorDTIAI “wealth window” is closing June 25thParadigm PressThe 2024 crypto bull run has already started — don’t get left behindInvestorPlaceThe asset beating inflation by 4xColonial MetalsThe 2024 Gold Rush: Unleashing Market PotentialPriority GoldCould Your Accounts Be Frozen?Allegiance GoldHe Is Giving Away BitcoinCrypto Swap ProfitsElon to Transform U.S. Economy? Porter & Company Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Corcept Therapeutics Incorporated Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
